BENTSUR RON 4
4 · Nuvectis Pharma, Inc. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
BENTSUR RON
DirectorChairman & CEO10% Owner
Transactions
- Purchase
Common Stock
2025-11-05$5.72/sh+5,000$28,600→ 3,525,924 total
Footnotes (1)
- [F1]Includes 676,759 shares of restricted stock.